Sawai Pharmaceutical Co Ltd (4555):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sawai Pharmaceutical Co Ltd (4555) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11529
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company’s products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. It provides products in the form of tablets, oral dispersing tablets, capsules, granule, injection, tape, ophthalmic and nasal solution, and syrup. Sawai Pharmaceutical caters to hospitals, general practitioners and dispensing pharmacies. The company has manufacturing facilities in Kanto, Osaka, Sanda and Kyusyu. It has its presence in Sapporo, Sendai, Kitakanto, Tokyo Daiichi, Tokyo Daini, Nagoya, Osaka, Hiroshima and Fukuoka. Sawai Pharmaceutical is headquartered in Osaka, Japan.

Sawai Pharmaceutical Co Ltd (4555) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 12
Sawai Pharma to Acquire Kashima Plant from Mitsubishi Tanabe Pharma Factory for USD39.3 Million 13
Partnerships 14
Upsher-Smith Enters into Marketing and Distribution Agreement 14
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 15
Upsher-Smith Labs Enters into Agreement 16
Upsher-Smith Labs Enters into Agreement with Bluepharma Industria Farmaceutica 17
Upsher-Smith Labs Enters into Agreement with Pharmathen 18
Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company 19
Upsher-Smith Labs Enters Into Development Agreement With Lundbeck 20
Equity Offering 21
Sawai Pharma to Raise USD37.7 Million in Private Placement of Shares 21
Asset Transactions 22
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 22
Acquisition 24
Sawai Pharma Sells 20% stake in Upsher-Smith Lab for USD211 Million 24
Sumitomo Corporation of America to Acquire 20% Stake in Sawai America for USD211 Million 25
Sawai Pharma Acquires Generic Pharmaceuticals Business of Upsher-Smith Labs from Acova for USD1.05 Billion 26
Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To US$555 Million 28
Sawai Pharmaceutical Co Ltd – Key Competitors 30
Sawai Pharmaceutical Co Ltd – Key Employees 31
Sawai Pharmaceutical Co Ltd – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Corporate Communications 33
May 15, 2018: Sawai Pharmaceutical Announce Personnel Changes 33
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 12
Sawai Pharma to Acquire Kashima Plant from Mitsubishi Tanabe Pharma Factory for USD39.3 Million 13
Upsher-Smith Enters into Marketing and Distribution Agreement 14
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 15
Upsher-Smith Labs Enters into Agreement 16
Upsher-Smith Labs Enters into Agreement with Bluepharma Industria Farmaceutica 17
Upsher-Smith Labs Enters into Agreement with Pharmathen 18
Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company 19
Upsher-Smith Labs Enters Into Development Agreement With Lundbeck 20
Sawai Pharma to Raise USD37.7 Million in Private Placement of Shares 21
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 22
Sawai Pharma Sells 20% stake in Upsher-Smith Lab for USD211 Million 24
Sumitomo Corporation of America to Acquire 20% Stake in Sawai America for USD211 Million 25
Sawai Pharma Acquires Generic Pharmaceuticals Business of Upsher-Smith Labs from Acova for USD1.05 Billion 26
Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To US$555 Million 28
Sawai Pharmaceutical Co Ltd, Key Competitors 30
Sawai Pharmaceutical Co Ltd, Key Employees 31
Sawai Pharmaceutical Co Ltd, Subsidiaries 32

List of Figures
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sawai Pharmaceutical Co Ltd (4555):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The TJX Companies, Inc.:企業の戦略・SWOT・財務情報
    The TJX Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The TJX Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kone Corporation
    Kone Corporation - Strategy, SWOT and Corporate Finance Report Summary Kone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Noel Gifts International Ltd. (543):企業の財務・戦略的SWOT分析
    Noel Gifts International Ltd. (543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Mincor Resources NL:企業の戦略・SWOT・財務情報
    Mincor Resources NL - Strategy, SWOT and Corporate Finance Report Summary Mincor Resources NL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ascend Therapeutics US LLC-製薬・医療分野:企業M&A・提携分析
    Summary Ascend Therapeutics US LLC (Ascend Therapeutics), a subsidiary of Besins Healthcare SA is a healthcare products provider that discovers, develops and markets transdermal drug delivery products. The company’s product comprises estrogel. Its estrogel is a non patch transdermal estrogen therapy …
  • Cadogan Petroleum Plc (CAD):石油・ガス:M&Aディール及び事業提携情報
    Summary Cadogan Petroleum Plc (Cadogan) is an independent upstream energy company that carries out exploration, development and production of oil and gas. It also conducts gas trading operations, which include the import of gas from European countries, and purchase and sale in the domestic market. T …
  • Compumedics Ltd (CMP):医療機器:M&Aディール及び事業提携情報
    Summary Compumedics Ltd (Compumedics) is a medical device company that develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems. It provides product categories such as sleep diagnostics, neurology diagnost …
  • Deutsche Telekom AG:企業の戦略・SWOT・財務情報
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cross Timbers Royalty Trust (CRT):企業の財務・戦略的SWOT分析
    Summary Cross Timbers Royalty Trust (Cross Timbers Royalty), a subsidiary of Exxon Mobil Corp is an oil and gas company that operates oil fields. It collects and distributes monthly net profits income from overriding interests to unit holders. It also establishes cash reserves for contingencies. Cro …
  • IOOF Holdings Ltd (IFL):企業の財務・戦略的SWOT分析
    IOOF Holdings Ltd (IFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Perenco Holdings:石油・ガス:M&Aディール及び事業提携情報
    Summary Perenco Holdings (Perenco) is an independent upstream energy company. It explores for, develops, produces, transports, and stores oil and gas. The company’s oil fields ranges from Northern Europe to Africa and Latin America to Southeast Asia. Through spot sales and long term sales agreements …
  • Aemetis Inc (AMTX):企業の財務・戦略的SWOT分析
    Summary Aemetis Inc (Aemetis) formerly AE Biofuels Inc is a renewable fuels and biochemicals company that produces advanced fuels and chemicals. The company’s products include biochemicals, renewable fuels, ethanol, ethanol co-products, glycerin, biodiesel, and edible oils, among others. It also pro …
  • Oman Cables Industry SAOG (OCAI):企業の財務・戦略的SWOT分析
    Oman Cables Industry SAOG (OCAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Quest Diagnostics Incorporated:企業の戦略・SWOT・財務情報
    Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report Summary Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Great-West Life & Annuity Insurance Co:企業の戦略的SWOT分析
    Great-West Life & Annuity Insurance Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Spire Inc (SR):石油・ガス:M&Aディール及び事業提携情報
    Summary Spire Inc (Spire), formerly Laclede Group, Inc., is a public utility, which carries out the sale, marketing and retail distribution of natural gas. It also markets natural gas and related activities on a non-regulated basis. The company also conducts transportation of liquid propane; real es …
  • Idexx Laboratories Inc (IDXX)-製薬・医療分野:企業M&A・提携分析
    Summary Idexx Laboratories Inc (IDEXX) is a diagnostics company. It develops, manufactures and distributes products and services for small animals and livestock. The company offers veterinary reference laboratory diagnostics and consulting services, point-of-care veterinary diagnostic products, micr …
  • Philippine Long Distance Telephone Company:企業の戦略・SWOT・財務情報
    Philippine Long Distance Telephone Company - Strategy, SWOT and Corporate Finance Report Summary Philippine Long Distance Telephone Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • STATS UK Ltd:企業の戦略的SWOT分析
    STATS UK Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • BASF SE (BAS)-製薬・医療分野:企業M&A・提携分析
    Summary BASF SE (BASF) is a chemical company, which carries out research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, e …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆